Literature DB >> 19502235

Cooperative regulation of the interferon regulatory factor-1 tumor suppressor protein by core components of the molecular chaperone machinery.

Vikram Narayan1, Mirjam Eckert, Alicja Zylicz, Maciej Zylicz, Kathryn L Ball.   

Abstract

Our understanding of the post-translational processes involved in regulating the interferon regulatory factor-1 (IRF-1) tumor suppressor protein is limited. The introduction of mutations within the C-terminal Mf1 domain (amino acids 301-325) impacts on IRF-1-mediated gene repression and growth suppression as well as the rate of IRF-1 degradation. However, nothing is known about the proteins that interact with this region to modulate IRF-1 function. A biochemical screen for Mf1-interacting proteins has identified an LXXLL motif that is required for binding of Hsp70 family members and cooperation with Hsp90 to regulate IRF-1 turnover and activity. These conclusions are supported by the finding that Hsp90 inhibitors suppress IRF-1-dependent transcription shortly after treatment, although at later time points inhibition of Hsp90 leads to an Hsp70-dependent depletion of nuclear IRF-1. Conversely, the half-life of IRF-1 is increased by Hsp90 in an ATPase-dependent manner leading to the accumulation of nuclear but not cytoplasmic IRF-1. This study begins to elucidate the role of the Mf1 domain of IRF-1 in orchestrating the recruitment of regulatory factors that can impact on both its turnover and transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502235      PMCID: PMC2757990          DOI: 10.1074/jbc.M109.019505

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Hsp90 as an anti-cancer target.

Authors:  Len Neckers; Edward Mimnaugh; Theodor W. Schulte
Journal:  Drug Resist Updat       Date:  1999-06       Impact factor: 18.500

Review 2.  Structure and mechanism of the Hsp90 molecular chaperone machinery.

Authors:  Laurence H Pearl; Chrisostomos Prodromou
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells.

Authors:  Kai Yang; Hexin Shi; Rong Qi; Shaogang Sun; Yujie Tang; Bianhong Zhang; Chen Wang
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

Review 4.  Chaperone machines in action.

Authors:  Helen R Saibil
Journal:  Curr Opin Struct Biol       Date:  2008-02-01       Impact factor: 6.809

5.  Structure of IRF-1 with bound DNA reveals determinants of interferon regulation.

Authors:  C R Escalante; J Yie; D Thanos; A K Aggarwal
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

6.  Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability.

Authors:  K Nakagawa; H Yokosawa
Journal:  Eur J Biochem       Date:  2000-03

7.  Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.

Authors:  David Dornan; Mirjam Eckert; Maura Wallace; Harumi Shimizu; Eleanor Ramsay; Ted R Hupp; Kathryn L Ball
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus.

Authors:  Mario D Galigniana; Jennifer M Harrell; Heather M O'Hagen; Mats Ljungman; William B Pratt
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

Review 9.  Chaperones in control of protein disaggregation.

Authors:  Krzysztof Liberek; Agnieszka Lewandowska; Szymon Zietkiewicz
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

10.  Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes.

Authors:  Diana A Stavreva; Waltraud G Müller; Gordon L Hager; Carolyn L Smith; James G McNally
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more
  15 in total

1.  ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein.

Authors:  Dawid Walerych; Malgorzata Gutkowska; Marcin P Klejman; Bartosz Wawrzynow; Zuzanna Tracz; Milena Wiech; Maciej Zylicz; Alicja Zylicz
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

2.  Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP.

Authors:  Vikram Narayan; Emmanuelle Pion; Vivien Landré; Petr Müller; Kathryn L Ball
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

3.  Intracellular activation of interferon regulatory factor-1 by nanobodies to the multifunctional (Mf1) domain.

Authors:  Angeli Möller; Emmanuelle Pion; Vikram Narayan; Kathryn L Ball
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

Review 4.  Targeting the dynamic HSP90 complex in cancer.

Authors:  Jane Trepel; Mehdi Mollapour; Giuseppe Giaccone; Len Neckers
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

5.  Regulation of PIDD auto-proteolysis and activity by the molecular chaperone Hsp90.

Authors:  A Tinel; M J Eckert; E Logette; S Lippens; S Janssens; B Jaccard; M Quadroni; J Tschopp
Journal:  Cell Death Differ       Date:  2010-10-22       Impact factor: 15.828

6.  A multiprotein binding interface in an intrinsically disordered region of the tumor suppressor protein interferon regulatory factor-1.

Authors:  Vikram Narayan; Petr Halada; Lenka Hernychová; Yuh Ping Chong; Jitka Žáková; Ted R Hupp; Borivoj Vojtesek; Kathryn L Ball
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

Review 7.  Hsp90 molecular chaperone inhibitors: are we there yet?

Authors:  Len Neckers; Paul Workman
Journal:  Clin Cancer Res       Date:  2012-01-01       Impact factor: 12.531

8.  The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.

Authors:  J L Schwartz; A N Shajahan; R Clarke
Journal:  Int J Breast Cancer       Date:  2011-07-03

9.  Exploiting the MDM2-CK1α protein-protein interface to develop novel biologics that induce UBL-kinase-modification and inhibit cell growth.

Authors:  Anne-Sophie Huart; Nicola J MacLaine; Vikram Narayan; Ted R Hupp
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Protein-Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP).

Authors:  Vikram Narayan; Vivien Landré; Jia Ning; Lenka Hernychova; Petr Muller; Chandra Verma; Malcolm D Walkinshaw; Elizabeth A Blackburn; Kathryn L Ball
Journal:  Mol Cell Proteomics       Date:  2015-09-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.